RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuso Pharmaceutical Industries Stock

Fuso Pharmaceutical Industries Revenue 2024

Fuso Pharmaceutical Industries Revenue

55.41 B JPY

Ticker

4538.T

ISIN

JP3823600006

In 2024, Fuso Pharmaceutical Industries's sales reached 55.41 B JPY, a 8.61% difference from the 51.02 B JPY sales recorded in the previous year.

The Fuso Pharmaceutical Industries Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
202455.4124,98
202351.0226,93
202249.6326,99
202149.2528,65
202046.927,29
201946.0729,15
201845.928,91
201746.7828,32
201645.7527,43
201547.0427,63
201449.129,90
201348.6131,51
201244.3627,49
201147.4728,37
201046.5629,54
200945.930,18
200843.9928,58
200743.1730,33
200642.6632,04
200541.9232,54

Fuso Pharmaceutical Industries Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fuso Pharmaceutical Industries, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fuso Pharmaceutical Industries from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fuso Pharmaceutical Industries’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fuso Pharmaceutical Industries. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fuso Pharmaceutical Industries’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fuso Pharmaceutical Industries’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fuso Pharmaceutical Industries’s growth potential.

Fuso Pharmaceutical Industries Revenue, EBIT and net profit per share

DateFuso Pharmaceutical Industries RevenueFuso Pharmaceutical Industries EBITFuso Pharmaceutical Industries Net Income
202455.41 B JPY1.96 B JPY1.38 B JPY
202351.02 B JPY2.21 B JPY1.61 B JPY
202249.63 B JPY1.92 B JPY1.48 B JPY
202149.25 B JPY2.35 B JPY1.61 B JPY
202046.9 B JPY1.01 B JPY707 M JPY
201946.07 B JPY1.26 B JPY894 M JPY
201845.9 B JPY798 M JPY970 M JPY
201746.78 B JPY656 M JPY861 M JPY
201645.75 B JPY296 M JPY10 M JPY
201547.04 B JPY796 M JPY340 M JPY
201449.1 B JPY2.8 B JPY1.98 B JPY
201348.61 B JPY3.82 B JPY4.87 B JPY
201244.36 B JPY480 M JPY372 M JPY
201147.47 B JPY1.84 B JPY1.14 B JPY
201046.56 B JPY321 M JPY518 M JPY
200945.9 B JPY302 M JPY-931 M JPY
200843.99 B JPY-502 M JPY107 M JPY
200743.17 B JPY540 M JPY-2.04 B JPY
200642.66 B JPY787 M JPY-1.93 B JPY
200541.92 B JPY1.3 B JPY566 M JPY

Fuso Pharmaceutical Industries stock margins

The Fuso Pharmaceutical Industries margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fuso Pharmaceutical Industries. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fuso Pharmaceutical Industries.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fuso Pharmaceutical Industries's sales revenue. A higher gross margin percentage indicates that the Fuso Pharmaceutical Industries retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fuso Pharmaceutical Industries's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fuso Pharmaceutical Industries's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fuso Pharmaceutical Industries's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fuso Pharmaceutical Industries. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fuso Pharmaceutical Industries's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fuso Pharmaceutical Industries Margin History

Fuso Pharmaceutical Industries Gross marginFuso Pharmaceutical Industries Profit marginFuso Pharmaceutical Industries EBIT marginFuso Pharmaceutical Industries Profit margin
202424.98 %3.54 %2.49 %
202326.93 %4.32 %3.15 %
202226.99 %3.88 %2.99 %
202128.65 %4.77 %3.26 %
202027.29 %2.15 %1.51 %
201929.15 %2.74 %1.94 %
201828.91 %1.74 %2.11 %
201728.32 %1.4 %1.84 %
201627.43 %0.65 %0.02 %
201527.63 %1.69 %0.72 %
201429.9 %5.7 %4.03 %
201331.51 %7.85 %10.02 %
201227.49 %1.08 %0.84 %
201128.37 %3.87 %2.41 %
201029.54 %0.69 %1.11 %
200930.18 %0.66 %-2.03 %
200828.58 %-1.14 %0.24 %
200730.33 %1.25 %-4.72 %
200632.04 %1.84 %-4.52 %
200532.54 %3.11 %1.35 %

Fuso Pharmaceutical Industries Aktienanalyse

What does Fuso Pharmaceutical Industries do?

Fuso Pharmaceutical Industries ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Fuso Pharmaceutical Industries's Sales Figures

The sales figures of Fuso Pharmaceutical Industries originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fuso Pharmaceutical Industries’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fuso Pharmaceutical Industries's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fuso Pharmaceutical Industries’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fuso Pharmaceutical Industries stock

How much revenue did Fuso Pharmaceutical Industries generate this year?

Fuso Pharmaceutical Industries has achieved a revenue of 55.41 B JPY this year.

How much was the turnover of the company Fuso Pharmaceutical Industries compared to the previous year?

The revenue of Fuso Pharmaceutical Industries has increased by 8.61% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fuso Pharmaceutical Industries?

The revenue of Fuso Pharmaceutical Industries is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fuso Pharmaceutical Industries measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fuso Pharmaceutical Industries so important for investors?

The revenue of Fuso Pharmaceutical Industries is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fuso Pharmaceutical Industries pay?

Over the past 12 months, Fuso Pharmaceutical Industries paid a dividend of 75 JPY . This corresponds to a dividend yield of about 3.42 %. For the coming 12 months, Fuso Pharmaceutical Industries is expected to pay a dividend of 75 JPY.

What is the dividend yield of Fuso Pharmaceutical Industries?

The current dividend yield of Fuso Pharmaceutical Industries is 3.42 %.

When does Fuso Pharmaceutical Industries pay dividends?

Fuso Pharmaceutical Industries pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Fuso Pharmaceutical Industries?

Fuso Pharmaceutical Industries paid dividends every year for the past 20 years.

What is the dividend of Fuso Pharmaceutical Industries?

For the upcoming 12 months, dividends amounting to 75 JPY are expected. This corresponds to a dividend yield of 3.42 %.

In which sector is Fuso Pharmaceutical Industries located?

Fuso Pharmaceutical Industries is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuso Pharmaceutical Industries kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuso Pharmaceutical Industries from 12/1/2024 amounting to 40 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuso Pharmaceutical Industries pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuso Pharmaceutical Industries in the year 2023?

In the year 2023, Fuso Pharmaceutical Industries distributed 75 JPY as dividends.

In which currency does Fuso Pharmaceutical Industries pay out the dividend?

The dividends of Fuso Pharmaceutical Industries are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuso Pharmaceutical Industries

Our stock analysis for Fuso Pharmaceutical Industries Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuso Pharmaceutical Industries Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.